体重变异性与2型糖尿病患者心血管结局及死亡风险:一项全国性队列研究
该研究基于韩国全国性队列,纳入2009至2010年间接受健康检查、入组后5年内有至少3次体重测量、随访至2017年底的624,237例2型糖尿病患者,用包括VIM在内的四项指标评估体重变异性,多变量校正Cox回归分析显示体重变异性与心肌梗死、卒中和全因死亡风险升高相关。
要点
- 体重变异性最高四分位组VIM对心肌梗死的HR为1.15(95%CI 1.10-1.20),与最低四分位组相比。
- 体重变异性最高四分位组VIM对卒中的HR为1.22(95%CI 1.18-1.26),与最低四分位组相比。
- 体重变异性最高四分位组VIM对全因死亡的HR为1.58(95%CI 1.53-1.62),与最低四分位组相比。
核心结论
- 体重变异性与2型糖尿病患者心肌梗死、卒中和全因死亡风险升高相关,可能作为该类患者心血管结局的预测指标。
- 作者认为,维持体重稳定的适当干预可能对2型糖尿病患者的健康结局产生积极影响。
研究设计与样本
- 基于韩国国民健康保险系统数据的全国性队列研究,纳入2009至2010年间接受健康检查的624,237例2型糖尿病患者,入组后5年内有至少3次体重测量,随访至2017年底。
- 使用包括均值独立变异性(VIM)在内的四项指标评估体重变异性,采用多变量校正Cox比例风险回归分析。
主要发现
- 随访期间记录心肌梗死15,832例、卒中25,038例、全因死亡44,716例。
- 体重变异性最高四分位组VIM对心肌梗死的HR为1.15(95%CI 1.10-1.20),与最低四分位组相比。
- 体重变异性最高四分位组VIM对卒中的HR为1.22(95%CI 1.18-1.26),与最低四分位组相比。
- 体重变异性最高四分位组VIM对全因死亡的HR为1.58(95%CI 1.53-1.62),与最低四分位组相比。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Obesity and type 2 diabetes are risk factors for cardiovascular diseases and mortality, and they commonly result in weight variabilities. We aimed to investigate the association between body weight variability and risk of major cardiovascular outcomes and mortality in individuals with type 2 diabetes using large-scale, nationwide cohort data on the Korean population. RESEARCH DESIGN AND METHODS: We enrolled 624,237 individuals with type 2 diabetes who underwent health examinations provided by the Korean National Health Insurance System between 2009 and 2010, with three or more body weight measurements within 5 years since enrollment and followed up until the end of 2017. We assessed body weight variability using four indices, including variability independent of the mean (VIM). A multivariate-adjusted Cox proportional hazards regression analysis was performed. RESULTS: During the follow-up, 15,832, 25,038, and 44,716 cases of myocardial infarction (MI), stroke, and all-cause mortality, respectively, were recorded. Body weight variability was associated with increased risks of major cardiovascular outcomes after adjusting for confounding variables. Compared with the hazard ratios (HRs) of the lowest quartile group, the HRs (95% CIs) of the highest quartile group of VIM for body weight were 1.15 (1.10-1.20), 1.22 (1.18-1.26), and 1.58 (1.53-1.62) for MI, stroke, and all-cause mortality, respectively. CONCLUSIONS: Body weight variability was associated with increased risks of MI, stroke, and all-cause mortality in patients with type 2 diabetes and may be a predictor of cardiovascular outcomes in such patients. Appropriate interventions to maintain stable weight could positively influence health outcomes in patients with type 2 diabetes.
引用
- Nam GE, Kim W, Han K, et al. Body Weight Variability and the Risk of Cardiovascular Outcomes and Mortality in Patients With Type 2 Diabetes: A Nationwide Cohort Study. Diabetes Care. 2020. PMID: 32641375. doi:10.2337/dc19-2552
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。